- VIX falls almost 10% amid US indices trying to recover losses
- CTAs may sell even more stocks if S&P 500 decline
- Fund managers have reduced cash and raised equity exposure
- VIX falls almost 10% amid US indices trying to recover losses
- CTAs may sell even more stocks if S&P 500 decline
- Fund managers have reduced cash and raised equity exposure
The VIX curve briefly inverted, meaning the near-term VIX was higher than futures — a sign traders see short-term uncertainty outweighing long-term risks.
-
Such inversions are rare and often coincide with market stress, but this one is described as mild, not panic-driven.
-
The VIX spot index jumped to around 24, the highest since the last tariff-driven sell-off in April, before stabilizing.
-
Analysts say this move shows that speculative excess has been flushed out, not that a crisis is brewing.
-
Susquehanna Group sees the inversion as a temporary reaction — traders expect turbulence but are not panicking.
-
Historically, most market bottoms happen during VIX backwardation, but those cases usually follow larger S&P 500 corrections (5%+) — unlike the mild pullback now.
-
Analysts caution that if the VIX fell back near 14, it would indicate dangerous complacency returning to the market.
-
Fund managers have reduced cash and raised equity exposure, which could limit buying power on future dips.
-
Commodity trading advisers (CTAs) have limited upside buying potential left, but could sell heavily (up to $46 billion) if the S&P 500 drops another few percent.
-
Overall sentiment: volatility likely to stay elevated, reflecting a market balancing optimism with caution after the tariff-related shock.
Source: xStation5
3 markets to watch next week - (17.10.2025)
Fed's Musalem remarks on the US economy and tariffs🗽
Precious metals decline 📉Gold down 2%; Silver loses 4%
US100 tries to recover🗽Sell-off hits uranium stocks
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
